Cite
HARVARD Citation
Mawad, R. et al. (2016). Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS. British journal of haematology. pp. 238-245. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mawad, R. et al. (2016). Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS. British journal of haematology. pp. 238-245. [Online].